Imerys S.A. (IMYSF)
| Market Cap | 2.35B +6.0% |
| Revenue (ttm) | 3.85B -2.2% |
| Net Income | -491.15M |
| EPS | -5.81 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 13.24 |
| Dividend | 0.87 (3.52%) |
| Ex-Dividend Date | May 20, 2026 |
| Volume | 755 |
| Open | 28.05 |
| Previous Close | n/a |
| Day's Range | 28.05 - 28.05 |
| 52-Week Range | 23.90 - 32.21 |
| Beta | 0.74 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 29, 2026 |
About Imerys
Imerys S.A. engages in the supply of specialty minerals for various industries across Europe, the Middle East, Africa, Asia Pacific, and America. The company offers performance minerals, such as additives for plastics, paints and coatings, filtration and life sciences, ceramics, and building products; specialty minerals used as processing aids for extreme work conditions, including refractory, foundry, abrasives, and building chemistry; and graphite and carbon minerals for energy transition and mobile energy markets. It also provides minerals, ... [Read more]
Financial Performance
In 2025, Imerys's revenue was 3.38 billion, a decrease of -6.14% compared to the previous year's 3.60 billion. Losses were -408.80 million, 330.3% more than in 2024.
Financial numbers in EUR Financial StatementsNews
Imerys Earnings Call Transcript: Q2 2026
Solid H1 2026 results with revenue up 1.8% and adjusted EBITDA up 10% at constant FX, driven by volume growth, firm pricing, and cost control. Guidance for FY 2026 remains cautious due to energy and geopolitical risks, but management is confident in delivering strong results.
Imerys Earnings release: Q2 2026
Imerys released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Imerys Slides: Q2 2026
Imerys has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Imerys Quarterly report: Q2 2026
Imerys has published its Q2 2026 quarterly earnings report on July 29, 2026.
Imerys Transcript: AGM 2026
The meeting reviewed stable 2025 financials amid market challenges, approved a €0.75 dividend, and ratified new board members. Strategic initiatives like Project Horizon and lithium investments were highlighted, with all resolutions passed and sustainability targets met.
Imerys Earnings Call Transcript: Q1 2026
Q1 2026 saw modest revenue growth and improved profitability at constant FX, despite currency headwinds and Middle East disruptions. Project Horizon is on track for significant cost savings, and price increases are being implemented to offset rising energy costs.
Imerys Earnings release: Q1 2026
Imerys released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Imerys Slides: Q1 2026
Imerys has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Imerys price target raised to EUR 23 from EUR 22 at Berenberg
Berenberg analyst Sebastian Bray raised the firm’s price target on Imerys (IMYSF) to EUR 23 from EUR 22 and keeps a Hold rating on the shares.
Imerys Earnings Call Transcript: Q4 2025
2025 revenue and EBITDA were flat year-over-year, with strong pricing offsetting weak volumes and FX headwinds. Project Horizon aims for €50–60 million annual cost savings, while CapEx will remain limited in 2026. A €467 million goodwill impairment impacted net income.
Imerys Annual report: Q4 2025
Imerys has published its Q4 2025 annual report on February 20, 2026.
Imerys Earnings release: Q4 2025
Imerys released its Q4 2025 earnings on February 20, 2026, summarizing the period's financial results.
Imerys Slides: Q4 2025
Imerys has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 20, 2026.
Imerys freezes UK lithium project to focus on France
Imerys has frozen its project to develop lithium production in Britain to focus on a more advanced venture in France, the minerals group said on Thursday.
French satellite operator Eutelsat taps Imerys exec as next finance chief
Eutelsat has appointed Sébastien Rouge as its new Chief Financial Officer, the French satellite operator said on Wednesday.
Imerys Earnings Call Transcript: Q3 2025
Revenue for the first nine months of 2025 was €2.6 billion, down 0.7% year-over-year, with adjusted EBITDA at €421 million and net profit at €110 million. Cost reduction initiatives and strategic acquisitions are underway, while market recovery is expected to be gradual, with Europe showing early signs of improvement.
Imerys Quarterly report: Q3 2025
Imerys has published its Q3 2025 quarterly earnings report on October 30, 2025.
Imerys Earnings release: Q3 2025
Imerys released its Q3 2025 earnings on October 30, 2025, summarizing the period's financial results.
Imerys Slides: Q3 2025
Imerys has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 30, 2025.
LBB Specialties and Imerys Form Specialty Distribution Partnership in North America
NORWALK, Conn., Sept. 15, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, is pleased to announce a new partnership with Imery...
Imerys Earnings Call Transcript: Q2 2025
H1 2025 saw resilient results with flat sales and higher underlying EBITDA, despite global uncertainty and weak European demand. Guidance for 2025 targets EUR 540–580 million Adjusted EBITDA, with growth expected in H2 from innovation, EVs, and construction recovery.
Imerys Quarterly report: Q2 2025
Imerys has published its Q2 2025 quarterly earnings report on July 29, 2025.
Imerys Earnings release: Q2 2025
Imerys released its Q2 2025 earnings on July 29, 2025, summarizing the period's financial results.
Imerys Slides: Q2 2025
Imerys has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 29, 2025.
Imerys Transcript: AGM 2025
The meeting reviewed strong 2024 financial results, approved a 7.4% dividend increase, and confirmed all resolutions, including board changes and capital authorizations. Strategic initiatives in lithium and sustainability advanced, while talc litigation and market uncertainties were addressed.